TGF-β signaling in Th17 cells promotes IL-22 production and colitis-associated colon cancer

Nature·May 25

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Research is exploring the role of TGF-β signaling in Th17 cells, which may be linked to the production of IL-22 and the development of colitis-associated colon cancer. The relationship between TGF-β signaling and Th17 cells is complex and has implications for various autoimmune diseases. Studies are investigating the interplay between TGF-β signaling, microRNAs, and other factors in the regulation of Th17 cells and their potential impact on immune pathogenesis.

Full coverage

Th17 cell pathogenicity in autoimmune disease

Nature·Sep 1

Interplay between microRNAs and TGF-β signaling in T cells: implications for Th9 differentiation and immune pathogenesis

Frontiers·Apr 21

Excessive Th1 responses due to the absence of TGF-β signaling cause autoimmune diabetes and dysregulated Treg cell homeostasis

PNAS·Feb 28

Interleukin-22 Influences the Th1/Th17 Axis

Frontiers·Feb 22

Intricacies of TGF-β signaling in Treg and Th17 cell biology

Nature·May 23

Metabolic checkpoints in the regulation of Th17 cells: implications for uveitis pathogenesis and therapy

Frontiers·Jan 26

Regulatory T cell therapy promotes TGF-β and IL-6-dependent pro-inflammatory Th17 cell generation by reducing IL-2

Nature·Aug 16

Cellular and Molecular Dynamics of Th17 Differentiation and its Developmental Plasticity in the Intestinal Immune Response

Frontiers·Feb 5

View original report at Nature ↗

Fetching the latest headlines…